Christoph Brandenbusch

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 7

Top Topics

Staphylococcus Aureus

Liquid Chromatography

Top Venues

Molecular pharmaceutics

Molecules (Basel, Switzerland)

Langmuir : the ACS journal of surfaces and colloids

This page only lists publications with an associated author ORCID identifier.

Publications

Peter Kroll, Julius Benke, Sabine Enders, Christoph Brandenbusch, Gabriele Sadowski
Influence of Temperature and Concentration on the Self-Assembly of Nonionic C i E j Surfactants: A Light Scattering Study. ACS omega 7 (8) (2022)
Peter Kroll, Gabriele Sadowski, Christoph Brandenbusch
Solubilization of Aldehydes and Amines in Aqueous C i E j Surfactant Aggregates: Solubilization Capacity and Aggregate Properties. Langmuir : the ACS journal of surfaces and colloids 38 (32) (2022)
Peter Kroll, Lara Exner, Christoph Brandenbusch, Gabriele Sadowski
Influence of Hydrophobic and Hydrophilic Chain Length of C i E j Surfactants on the Solubilization of Active Pharmaceutical Ingredients. Molecular pharmaceutics 20 (2) (2022)
Peter Kroll, Lara Exner, Christoph Brandenbusch, Gabriele Sadowski
Influence of Hydrophobic and Hydrophilic Chain Length of C i E j Surfactants on the Solubilization of Active Pharmaceutical Ingredients. Molecular pharmaceutics (2022)
Peter Kroll, Lara Exner, Christoph Brandenbusch, Gabriele Sadowski
Influence of Hydrophobic and Hydrophilic Chain Length of C i E j Surfactants on the Solubilization of Active Pharmaceutical Ingredients. Molecular pharmaceutics 20 (2) (2022)
Tanja Stolzke, Franziska Krieg, Tao Peng, Hailong Zhang, Olaf Häusler, Christoph Brandenbusch
Hydroxylpropyl-β-cyclodextrin as Potential Excipient to Prevent Stress-Induced Aggregation in Liquid Protein Formulations. Molecules (Basel, Switzerland) 27 (16) (2022)
Peter Kroll, Lara Exner, Christoph Brandenbusch, Gabriele Sadowski
Influence of Hydrophobic and Hydrophilic Chain Length of C i E j Surfactants on the Solubilization of Active Pharmaceutical Ingredients. Molecular pharmaceutics 20 (2) (2022)